Femalegra (Sildenafil 100mg, Off-Label for Women)
Femalegra is a 100mg sildenafil citrate tablet manufactured in India by Sunrise Remedies and marketed for women through international online pharmacies. Like Female Viagra and Lady Era, the product is off-label and not approved for any female indication.
- Active ingredients
- Sildenafil Citrate
- Manufacturer
- Sunrise Remedies
- Dosage forms
- tablet
- Available dosages
- 100mg
- Category
- Women's Sexual Health
What is it?
Femalegra is a brand of sildenafil citrate 100mg tablets manufactured by Sunrise Remedies, an Indian pharmaceutical company. Like Female Viagra and Lady Era, the product is marketed for women through international online pharmacies despite the absence of regulatory approval for any female sexual indication. The active ingredient is identical to that in standard Viagra; differences from Female Viagra and Lady Era are limited to manufacturer, packaging and price. Sunrise Remedies also manufactures Lady Era, positioning Femalegra alongside it as an alternative product line.
Active ingredients
Each Femalegra tablet contains 100mg of sildenafil citrate, the same selective PDE5 inhibitor used for erectile dysfunction in men. The pharmacological mechanism — increasing genital blood flow through cGMP accumulation — is theoretically applicable to women, since PDE5 is also present in female genital tissue. However, controlled clinical evidence does not support routine use for female sexual dysfunction, and the molecule has not received approval for any female sexual indication.
Forms and dosages
Femalegra is supplied as 100mg film-coated tablets, often pink in colour to differentiate from male sildenafil products. International online pharmacies typically recommend one tablet 30 to 60 minutes before planned sexual activity, with a maximum of one dose per 24 hours. Because there is no approved female indication, no validated dosing schedule applies. According to general prescribing principles for sildenafil, women considering use should consult a healthcare provider rather than self-medicating.
Indications
Femalegra has no approved indication. Like other sildenafil-based products marketed for women, the molecule has not been authorised by the FDA, EMA or other major regulators for any female sexual dysfunction. The two FDA-approved options for hypoactive sexual desire disorder in premenopausal women — flibanserin (Addyi) and bremelanotide (Vyleesi) — are not sildenafil-based and act through different mechanisms. According to clinical guidelines, off-label sildenafil use in women should not be undertaken without medical supervision.
How it works
Sildenafil citrate inhibits PDE5, allowing cGMP to accumulate in vascular smooth muscle and increasing local blood flow during sexual arousal. In men this supports erection; in women, the theory is that increased genital blood flow could improve arousal and lubrication. Clinical trials in women have produced inconsistent results, and the molecule does not act on sexual desire — the dominant complaint in many female sexual dysfunctions. Sexual stimulation is required for any expected effect, just as in male use.
Frequently asked questions
How does Femalegra differ from Female Viagra and Lady Era? ▾
All three products contain sildenafil citrate 100mg and target the same off-label market. The differences are mainly in manufacturer (Sunrise Remedies for Femalegra and Lady Era; various manufacturers for Female Viagra) and packaging. None are approved by the FDA, EMA or other major regulators for any female sexual indication. Pricing on international online pharmacies is usually similar across all three brands.
Is Femalegra effective for low libido? ▾
Sildenafil citrate, the active ingredient, does not act on sexual desire and is unlikely to help with hypoactive sexual desire disorder. It targets blood flow rather than central nervous system desire pathways. For low libido in premenopausal women, the FDA-approved options are flibanserin (Addyi) and bremelanotide (Vyleesi). According to clinical guidelines, low desire should be evaluated medically before any pharmacological treatment, and self-medication with off-label sildenafil-based products is discouraged.
Are there safety concerns specific to women using Femalegra? ▾
Standard sildenafil contraindications apply: nitrate co-administration is contraindicated due to severe hypotension risk, and severe cardiovascular disease, recent stroke or heart attack, severe hepatic impairment and known sildenafil hypersensitivity require caution. Safety data in pregnancy and breastfeeding is limited. According to regulators, the additional risk of counterfeit or mis-dosed material in unverified online channels should be considered before purchase.
Can Femalegra be combined with PDE5 inhibitors used by male partners? ▾
Femalegra contains the same active ingredient as men's PDE5 inhibitors used for erectile dysfunction, but each partner is independently dosed; there is no pharmacological interaction between separate doses taken by different individuals. However, simultaneous off-label use of sildenafil by both partners does not constitute a recognised clinical indication and is not supported by evidence. According to clinical guidelines, sexual concerns affecting both partners are best evaluated jointly with a clinician.
Should women self-medicate with Femalegra? ▾
No. According to clinical guidelines, persistent female sexual concerns should first be evaluated by a qualified clinician — gynaecologist, urologist or sexual medicine specialist. This evaluation explores hormonal, psychological and relationship factors that pharmacological treatment alone may not address. Off-label sildenafil should not replace this assessment, and online-only purchases bypass the safety review that any prescription-strength medicine should receive.
Related medications
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.